KalVista Pharmaceuticals, Inc. (KALV) Stock price, Description, News & Info

#Thinksabio latest news

KalVista Pharmaceuticals Presents New Data Highlighting Patient Satisfaction with EKTERLY® (sebetralstat) and its Potential in Children Ages 2-11 at the ACAAI 2025 Annual Scientific Meeting